Melarsoprol

美拉胂醇

Report date: 2022/02/21 14:43:23

NME

Base Information

Drug NameMelarsoprol

Drug Alias Namemelarsoprol胂密胺melarsoprolum硫胂密胺Specia +[8]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPyruvate kinase isozymes R/L inhibitorsPyruvate kinase isozymes M1/M2 inhibitors

TargetsPyruvate kinase isozymes R/LPyruvate kinase isozymes M1/M2

Therapy Area/IndicationsTrypanosomiasis, African

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsTrypanosomiasis, African

Inactive IndicationsN/A

ATC CodeP01CD01